Shine, DOE iron out details on Mo-99 production

2022 01 06 22 39 5016 2021 01 06 Shine Facility 20220106225925

Shine Medical Technologies and the U.S. Department of Energy (DOE) have inked contracts covering details for production of molybdenum-99 (Mo-99) at the company's new facility in Janesville, WI.

The contracts are the first to be signed under the DOE's Uranium Lease and Take-back Program. Under the contracts, the DOE National Nuclear Security Administration (NNSA) will provide Shine with the low-enriched uranium necessary to produce Mo-99, while Shine's contract with the DOE Office of Environmental Management details requirements surrounding the return of any resulting radioactive waste without a commercial disposition path once Mo-99 production is complete.

Shine's facility in Janesville, WI, under construction.Shine's facility in Janesville, WI, under construction.

"Signing these contracts with Shine is a crucial step toward medical isotope autonomy for the United States," said Corey Hinderstein, NNSA Deputy Administrator for Defense Nuclear Nonproliferation, in a news release.

Shine is steadily progressing toward Mo-99 production capability at its Wisconsin plant.

Page 1 of 435
Next Page